Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12615000179538
Ethics application status
Approved
Date submitted
7/08/2014
Date registered
24/02/2015
Date last updated
13/10/2024
Date data sharing statement initially provided
19/08/2019
Date results provided
19/08/2019
Type of registration
Retrospectively registered

Titles & IDs
Public title
Nerve transfer surgery in the upper limb of patients with tetraplegia
Scientific title
The effect of nerve transfer surgery on upper limb function in patients with tetraplegia after traumatic spinal cord injury
Secondary ID [1] 285121 0
None
Universal Trial Number (UTN)
U1111-1160-1375
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Spinal Cord Injury 292680 0
Condition category
Condition code
Neurological 292995 292995 0 0
Other neurological disorders
Injuries and Accidents 293235 293235 0 0
Other injuries and accidents

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Nerve transfer surgery involves the transfer of an expendable, intact nerve (or fascicle of a nerve) to the non-functional nerve of a paralysed muscle. Nerves are carefully identified and dissected to prepare for the transfer. The donor and recipient nerves are divided in close proximity and are then co-apted or joined with the use of an operating microscope. The duration of surgery varies depending on the nerves involved but can range from 1-2 hours per transfer. Post operatively, the arm is immobilised for 2-3 weeks to protect the transfer.

After the period of immobilisation, rehabilitation is provided by an occupational therapist. Between 3 weeks to 6 months, depending on target nerve, daily pairing exercises (pairing donor muscle action to recipient muscle action) are performed till the first flickers of activity in recipient muscle/s are observed. Pairing continues till muscle strength is M3 or stable for 3 months, then dissociation between donor and recipient actions is encouraged. A home exercise program will be completed 2 – 5 times a day, initially for pairing exercises then active strengthening, totalling no more than 15 minutes each day.
Intervention code [1] 289972 0
Treatment: Surgery
Intervention code [2] 289973 0
Rehabilitation
Comparator / control treatment
Not applicable
Control group
Uncontrolled

Outcomes
Primary outcome [1] 292857 0
Change in score on Action Research Arm Test
Timepoint [1] 292857 0
24 months post-operatively
Primary outcome [2] 292858 0
Change in score on the Grasp-Release Test
Timepoint [2] 292858 0
24 months post-operatively
Primary outcome [3] 292859 0
Change in score on the Spinal Cord Independence Measure
Timepoint [3] 292859 0
24 months post-operatively
Secondary outcome [1] 309814 0
Histological description of nerve tissue samples
Timepoint [1] 309814 0
At time of surgery
Secondary outcome [2] 309815 0
Neurophysiological assessments including nerve conduction studies of donor nerves and needle electromyography of donor muscles.
Timepoint [2] 309815 0
At time of surgery
Secondary outcome [3] 309816 0
Cost-benefit analysis using the Health Utilities Index Mark 3
Timepoint [3] 309816 0
24 months post-operatively

Eligibility
Key inclusion criteria
1. Complete or incomplete tetraplegia with C5 – C7 motor neurological level
2. Spinal injury sustained within the last 12-18 months
3. Assessed as suitable for nerve transfer surgery by the surgical and occupational therapy team at the Upper
Limb Program Multidisciplinary Clinic at Royal Talbot.
4. Consent to nerve transfer surgery after being fully informed about expected outcomes, potential risks, surgical
procedure, recovery time, postoperative therapy commitments and the same for the equivalent tendon transfers
5. Able to comply with therapy protocols postoperatively
Minimum age
12 Years
Maximum age
70 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
1. Accompanying head injury, brachial plexus or peripheral nerve injury at the time of, or preceding the spinal cord
injury
2. Any other pre-existing neurological condition
3. Cognitive impairment limiting ability to consent to surgery or comply with postoperative rehabilitation
4. Skeletal or joint injury significantly limiting passive range of movement across a joint relevant to the proposed
nerve transfer

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
27/01/2014
Actual
11/04/2014
Date of last participant enrolment
Anticipated
Actual
22/11/2016
Date of last data collection
Anticipated
24/12/2018
Actual
24/12/2018
Sample size
Target
15
Accrual to date
Final
16
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 2821 0
Austin Health - Austin Hospital - Heidelberg
Recruitment postcode(s) [1] 8508 0
3084 - Heidelberg

Funding & Sponsors
Funding source category [1] 289733 0
Charities/Societies/Foundations
Name [1] 289733 0
Institute for Safety Compensation and Recovery Research
Country [1] 289733 0
Australia
Primary sponsor type
University
Name
The University of Melbourne
Address
Parkville, VIC 3010
Country
Australia
Secondary sponsor category [1] 288426 0
None
Name [1] 288426 0
Address [1] 288426 0
Country [1] 288426 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 291468 0
Austin Health Human Research Ethics Committee
Ethics committee address [1] 291468 0
Ethics committee country [1] 291468 0
Australia
Date submitted for ethics approval [1] 291468 0
Approval date [1] 291468 0
18/12/2013
Ethics approval number [1] 291468 0
HREC/13/Austin/245

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 50530 0
Prof Mary Galea
Address 50530 0
Department of Medicine (Royal Melbourne Hospital)
The University of Melbourne
Parkville VIC 3010
Country 50530 0
Australia
Phone 50530 0
+61 3 8387 2017
Fax 50530 0
Email 50530 0
[email protected]
Contact person for public queries
Name 50531 0
Natasha van Zyl
Address 50531 0
Department of Plastic and Reconstructive Surgery
Austin Health
PO Box 5555
Heidelberg VIC 3084
Country 50531 0
Australia
Phone 50531 0
+61 3 9496 3865
Fax 50531 0
Email 50531 0
[email protected]
Contact person for scientific queries
Name 50532 0
Mary Galea
Address 50532 0
Department of Medicine (Royal Melbourne Hospital)
The University of Melbourne
Parkville VIC 3010
Country 50532 0
Australia
Phone 50532 0
+61 3 8387 2017
Fax 50532 0
Email 50532 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
SourceTitleYear of PublicationDOI
Dimensions AIMorphology of Donor and Recipient Nerves Utilised in Nerve Transfers to Restore Upper Limb Function in Cervical Spinal Cord Injury2016https://doi.org/10.3390/brainsci6040042
N.B. These documents automatically identified may not have been verified by the study sponsor.